Sulfur Nanoparticle-Decorated Nickel Cobalt Sulfide Hetero-Nanostructures with Enhanced Energy Storage for High-Performance Supercapacitors.

Transition-metal sulfides exaggerate higher theoretical capacities and were considered a type of prospective nanomaterials for energy storage; their inherent weaker conductivities and lower electrochemical active sites limited the commercial applications of the electrodes. The sheet-like nickel cobalt sulfide nanoparticles with richer sulfur vacancies were fabricated by a two-step hydrothermal technique. The sheet-like nanoparticles self-combination by ultrathin nanoparticles brought active electrodes entirely contacted with the electrolytes, benefiting ion diffusion and charges/discharges. Nevertheless, defect engineers of sulfur vacancy at the atomic level raise the intrinsic conductivities and improve the active sites for energy storage functions. As a result, the gained sulfur-deficient NiCo2S4 nanosheets consist of good specific capacitances of 971 F g-1 at 2 A g-1 and an excellent cycle span, retaining 88.7% of the initial capacitance over 3500 cyclings. Moreover, the values of capacitance results exhibited that the fulfilling characteristic of the sample was a combination of the hydrothermal procedure and the surface capacitances behavior. This novel investigation proposes a new perspective to importantly improve the electrochemical performances of the electrode by the absolute engineering of defects and morphologies in the supercapacitor field.

Chemically Synthesized Iron-Oxide-Based Pure Negative Electrode for Solid-State Asymmetric Supercapacitor Devices.

Among energy storage devices, supercapacitors have received considerable attention in recent years owing to their high-power density and extended cycle life. Researchers are currently making efforts to improve energy density using different asymmetric cell configurations, which may provide a wider potential window. Many studies have been conducted on positive electrodes for asymmetric supercapacitor devices; however, studies on negative electrodes have been limited. In this study, iron oxides with different morphologies were synthesized at various deposition temperatures using a simple chemical bath deposition method. A nanosphere-like morphology was obtained for α-Fe2O3. The obtained specific capacitance (Cs) of α-Fe2O3 was 2021 F/g at a current density of 4 A/g. The negative electrode showed an excellent capacitance retention of 96% over 5000 CV cycles. The fabricated asymmetric solid-state supercapacitor device based on α-Fe2O3-NF//Co3O4-NF exhibited a Cs of 155 F/g and an energy density of 21 Wh/kg at 4 A/g.

Photocatalytic degradation of tetracycline antibiotics using hydrothermally synthesized two-dimensional molybdenum disulfide/titanium dioxide composites.

Tetracycline (TC) is a persistent antibiotic used in many countries, including China, India, and the United States of America (USA), because of its low price and effectiveness in enhancing livestock production. However, such antibiotics can have toxic effects on living organisms via complexation with metals, and their accumulation leading to teratogenicity and carcinogenicity. In this study, two-dimensional molybdenum disulfide/titanium dioxide (MoS2/TiO2) composites with different amounts of molybdenum disulfide (MoS2) were prepared via a simple, cost-effective, and pollution-free hydrothermal route. The synthesized MoS2/TiO2 microstructures were thoroughly characterized and their performance for the photocatalytic degradation of antibiotics such as TC was investigated. In the degradation experiments, the photocatalytic activities of TiO2 and the MoS2/TiO2 composites were compared, and the effects of different parameters, such as catalyst dose and electrolyte solution pH, were investigated. Under irradiation, the MoS2/TiO2 composites possessed superior photodegradation activity toward TC because of their excellent adsorption abilities, suitable band positions, and large surface areas as well as the effective charge-transfer ability of MoS2. Kinetics studies revealed that the photocatalytic degradation process followed pseudo-first-order reaction kinetics. In addition, a degradation mechanism for TC was proposed.

Nanoflakes-like nickel cobaltite as active electrode material for 4-nitrophenol reduction and supercapacitor applications.

Catalytic reduction of nitroaromatic compounds present in wastewater by nanostructured materials is a promising process for wastewater treatment. A multifunctional electrode based on ternary spinal nickel cobalt oxide is used in the catalytic reduction of a nitroaromatic compound and supercapacitor application. In this study, we designed nanoflakes- like nickel cobaltite (NiCo2O4) using a simple, chemical, cost-effective hydrothermal method. Nanoflakes- like NiCo2O4 samples are tested as catalysts toward rapid reduction of 4-nitrophenol and as electrode materials for supercapacitors. The conversion of 4-nitrophenol into 4-aminophenol is achieved using a reducing agents like sodium borohydride and NiCo2O4 catalyst. Effect of catalyst loading, 4-nitrophenol and sodium borohydride concentrations on the catalytic performance of 4-nitrophenol is studied. As sodium borohydride concentration increases the catalytic efficiency of 4-nitrophenol increased due to more BH4- ions available which provides more electrons for catalytic reduction of 4-nitrophenol. Catalytic reduction of 4-nitrophenol using sodium borohydride as a reducing agent was based on the Langmuir-Hinshelwood mechanism. This mechanism follows the apparent pseudo first order reaction kinetics. Additionally, NiCo2O4 electrode is used for energy storage application. The nanoflakes-like NiCo2O4 electrode deposited at 120 °C shows a higher specific capacitance than samples synthesized at 100 and 140 °C. The maximum specific capacitance observed for NiCo2O4 electrode is 1505 Fg-1 at a scan rate of 5 mV s-1 with high stability of 95% for 5000 CV cycles.

Inhibition of senescence and promotion of the proliferation of chondrocytes from articular cartilage by CsA and FK506 involves inhibition of p38MAPK.

Cyclosporine A (CsA) and tacrolimus (FK506) are the most important immunosuppressive compounds that block the activation of helper T-cells. In this study, we investigated the effects of CsA and FK506 on growth and senescence of articular chondrocytes. Chondrocytes from young rabbit cartilage entered senescence after 8.6 ± 0.8 population doublings (PDs), while chondrocytes treated with CsA and FK506 entered senescence after 12.3 ± 1.4 and 13.7 ± 0.6 PDs, respectively. Furthermore, chondrocytes from the cartilage of old rabbits were senescent after 2.6 ± 0.9 PDs, whereas those treated with CsA and FK506 were senescent after 8.2 ± 1.8 and 6.9 ± 1.6 PDs, respectively. These compounds also inhibited senescence induction of chondrocytes in a high-cell density pellet culture system. We previously reported that p38MAPK plays a critical role in the onset of senescence in chondrocyte. This study revealed that the phosphorylation of p38MAPK was inhibited by either CsA or FK506. The early onset of senescence in chondrocyte harboring MKK6E, which is a constitutively-active form of MKK6 and increases p38MAPK phosphorylation, was blocked by CsA. These results suggest that CsA and FK506 increase the proliferation and inhibit the senescence of articular chondrocytes through inactivation of p38MAPK.

Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3.

TLR2 promotes NLRP3 inflammasome activation via an early MyD88-IRAK1-dependent pathway that provides a priming signal (signal 1) necessary for activation of the inflammasome by a second potassium-depleting signal (signal 2). Here we show that TLR3 binding to dsRNA promotes post-translational inflammasome activation through intermediate and late TRIF/RIPK1/FADD-dependent pathways. Both pathways require the scaffolding but not the catalytic function of caspase-8 or RIPK1. Only the late pathway requires kinase competent RIPK3 and MLKL function. Mechanistically, FADD/caspase-8 scaffolding function provides a post-translational signal 1 in the intermediate pathway, whereas in the late pathway it helps the oligomerization of RIPK3, which together with MLKL provides both signal 1 and 2 for inflammasome assembly. Cytoplasmic dsRNA activates NLRP3 independent of TRIF, RIPK1, RIPK3 or mitochondrial DRP1, but requires FADD/caspase-8 in wildtype macrophages to remove RIPK3 inhibition. Our study provides a comprehensive analysis of pathways that lead to NLRP3 inflammasome activation in response to dsRNA.

The ketone metabolite ß-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.

The ketone bodies ß-hydroxybutyrate (BHB) and acetoacetate (AcAc) support mammalian survival during states of energy deficit by serving as alternative sources of ATP. BHB levels are elevated by starvation, caloric restriction, high-intensity exercise, or the low-carbohydrate ketogenic diet. Prolonged fasting reduces inflammation; however, the impact that ketones and other alternative metabolic fuels produced during energy deficits have on the innate immune response is unknown. We report that BHB, but neither AcAc nor the structurally related short-chain fatty acids butyrate and acetate, suppresses activation of the NLRP3 inflammasome in response to urate crystals, ATP and lipotoxic fatty acids. BHB did not inhibit caspase-1 activation in response to pathogens that activate the NLR family, CARD domain containing 4 (NLRC4) or absent in melanoma 2 (AIM2) inflammasome and did not affect non-canonical caspase-11, inflammasome activation. Mechanistically, BHB inhibits the NLRP3 inflammasome by preventing K(+) efflux and reducing ASC oligomerization and speck formation. The inhibitory effects of BHB on NLRP3 are not dependent on chirality or starvation-regulated mechanisms like AMP-activated protein kinase (AMPK), reactive oxygen species (ROS), autophagy or glycolytic inhibition. BHB blocks the NLRP3 inflammasome without undergoing oxidation in the TCA cycle, and independently of uncoupling protein-2 (UCP2), sirtuin-2 (SIRT2), the G protein-coupled receptor GPR109A or hydrocaboxylic acid receptor 2 (HCAR2). BHB reduces NLRP3 inflammasome-mediated interleukin (IL)-1ß and IL-18 production in human monocytes. In vivo, BHB or a ketogenic diet attenuates caspase-1 activation and IL-1ß secretion in mouse models of NLRP3-mediated diseases such as Muckle-Wells syndrome, familial cold autoinflammatory syndrome and urate crystal-induced peritonitis. Our findings suggest that the anti-inflammatory effects of caloric restriction or ketogenic diets may be linked to BHB-mediated inhibition of the NLRP3 inflammasome.

Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome.

Activation of the NLRP3 inflammasome by diverse stimuli requires a priming signal from TLRs and an activation signal from purinergic receptors or pore-forming toxins. In this study, we demonstrate, through detailed analysis of NLRP3 activation in macrophages deficient in key downstream TLR signaling molecules, that MyD88 is required for an immediate early phase, whereas Toll/IL-1R domain-containing adapter inducing IFN-ß is required for a subsequent intermediate phase of posttranslational NLRP3 activation. Both IL-1R-associated kinase (IRAK) 1 and IRAK4 are critical for rapid activation of NLRP3 through the MyD88 pathway, but only IRAK1 is partially required in the Toll/IL-1R domain-containing adapter inducing IFN-ß pathway. IRAK1 and IRAK4 are also required for rapid activation of NLRP3 by Listeria monocytogenes, as deletion of IRAK1 or IRAK4 led to defective inflammasome activation. These findings define the pathways that lead to rapid NLRP3 activation and identify IRAK1 as a critical mediator of a transcription-independent,inflammasome-dependent early warning response to pathogenic infection.

A novel role for the mitochondrial HTRA2/OMI protease in aging.

HTRA2/OMI is an ATP-independent serine protease located in the intermembrane space of the mitochondria and is thought to function as a protein quality control protease. Our previous studies showed that loss of the enzymatic activity of HTRA2 due to a Ser276Cys missense mutation in its catalytic domain is associated with early onset neurodegeneration, multiple tissue atrophy and premature lethality in homozygous htra2 (mnd2) mice, suggesting that HTRA2 is neuroprotective. To further investigate the role of HTRA2 in neuronal cell survival and the impact of its loss of function in non-neuronal tissues of adult mice, we generated transgenic htra2 (mnd2) mice expressing a neuron-targeted human HTRA2 transgene. Notably, this HTRA2 transgene rescues htra2 (mnd2) mice from early onset neurodegeneration, and other phenotypic abnormalities and prevents their early death, indicating that HTRA2 activity in neuronal mitochondria is important for neuronal cell survival. However, as the rescued htra2 (mnd2) mice grow older they exhibit specific phenotypic abnormalities indicative of premature aging. These include premature weight loss, osteoporosis, lordokyphosis, muscle atrophy, heart enlargement, increased autophagy and reduced life span. There is also a significant increase in the levels of clonally expanded mitochondrial DNA (mtDNA) deletions in their tissues. Our findings suggest that HTRA2-regulated protein quality control in the intermembrane space of mitochondria is important for the maintenance of mitochondrial homeostasis, and loss of HTRA2 activity can lead to both neurodegeneration and aging.

Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.

The NLRP3 inflammasome is a key component of the innate immune response to pathogenic infection and tissue damage. It is also involved in the pathogenesis of a number of human diseases, including gouty arthritis, silicosis, atherosclerosis, and type 2 diabetes. The assembly of the NLRP3 inflammasome requires a priming signal derived from pattern recognition or cytokine receptors, followed by a second signal derived from extracellular ATP, pore-forming toxins, or crystalline materials. How these two signals activate the NLRP3 inflammasome is not yet clear. Here, we show that in mouse macrophages, signaling by the pattern recognition receptor TLR4 through MyD88 can rapidly and non-transcriptionally prime NLRP3 by stimulating its deubiquitination. This process is dependent on mitochondrial reactive oxygen species production and can be inhibited by antioxidants. We further show that signaling by ATP can also induce deubiquitination of NLRP3 by a mechanism that is not sensitive to antioxidants. Pharmacological inhibition of NLRP3 deubiquitination completely blocked NLRP3 activation in both mouse and human cells, indicating that deubiquitination of NLRP3 is required for its activation. Our findings suggest that NLRP3 is activated by a two-step deubiquitination mechanism initiated by Toll-like receptor signaling and mitochondrial reactive oxygen species and further potentiated by ATP, which could explain how NLRP3 is activated by diverse danger signals.

The AIM2 inflammasome is critical for innate immunity to Francisella tularensis.

Francisella tularensis, the causative agent of tularemia, infects host macrophages, which triggers production of the proinflammatory cytokines interleukin 1beta (IL-1beta) and IL-18. We elucidate here how host macrophages recognize F. tularensis and elicit this proinflammatory response. Using mice deficient in the DNA-sensing inflammasome component AIM2, we demonstrate here that AIM2 is required for sensing F. tularensis. AIM2-deficient mice were extremely susceptible to F. tularensis infection, with greater mortality and bacterial burden than that of wild-type mice. Caspase-1 activation, IL-1beta secretion and cell death were absent in Aim2(-/-) macrophages in response to F. tularensis infection or the presence of cytoplasmic DNA. Our study identifies AIM2 as a crucial sensor of F. tularensis infection and provides genetic proof of its critical role in host innate immunity to intracellular pathogens.

Bcl-xL and E1B-19K proteins inhibit p53-induced irreversible growth arrest and senescence by preventing reactive oxygen species-dependent p38 activation.

In this study, we describe novel functions of the anti-apoptotic Bcl-2 family proteins. Bcl-x(L) and E1B-19K were found to inhibit p53-induced irreversible growth arrest and senescence, but not to inhibit transient growth arrest, implying that Bcl-x(L) and E1B-19K are specifically involved in senescence without participating in growth arrest. We provide several lines of evidences showing that the functions of Bcl-x(L) and E1B-19K to prevent generation of reactive oxygen species (ROS) are important to inhibit senescence induction. First, we found that that ROS are increased during p53-induced senescence. Moreover, Bcl-x(L) and E1B-19K inhibit this p53-induced ROS generation. Second, antioxidants prevent the induction of senescence and ROS by p53, but not the persistence of the senescence phenotype. Third, the anti-senescence functions of Bcl-x(L) and E1B-19K were suppressed by adding exogenous ROS. These results suggest that Bcl-x(L) and E1B-19K inhibit senescence induction by preventing ROS generation. Furthermore, p38 kinase was found to be activated during p53-induced senescence, but not in cells expressing Bcl-x(L) or E1B-19K, or in cells treated with anti-oxidants. Consistently, a chemical inhibitor of p38 kinase, SB203580, was found to inhibit p53-induced senescence, but only when treated before the cellular commitment to senescence, implying that p38 kinase is necessary for senescence induction. Therefore, Bcl-x(L) and E1B-19K inhibit p53-induced senescence by preventing ROS generation, which in turn leads to the activation of p38 kinase. These results also suggest that the oncogenic potential of Bcl-2 is due to its ability to inhibit senescence as well as apoptosis.